Feasibility of a Video-oculography in Patients With Huntington's Disease VOG-HD Study
Not Applicable
- Conditions
- Huntington Disease
- Registration Number
- NCT02563418
- Lead Sponsor
- University Hospital, Angers
- Brief Summary
The purpose of this study is to know the limits of feasibility of a reliable oculomotor record for patient with Huntington's disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- Corrected visual acuity >1/10
- Aged over 18 years
- Patient with the mutation that is to say the presence of an abnormal number of trinuclide: CAG> 38 in the first exon of the huntingtin gene.
- Total Functional Capacity Scale (CFT) ≥ 3
Exclusion Criteria
- Patients or trustworthy person who have not given their written consent, informed and signed.
- Patients are not affiliated or who are not entitled to Social Security
- Private patients of liberty by administrative or judicial decision, or patients supervision
- Associated disease with neurological repercussions
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method saccadic measures with the eye tracker 1 day one measure in the evening and one in the afternoon
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie oculomotor dysfunction in Huntington's disease as studied in NCT02563418?
How does video-oculography compare to standard eye-tracking methods in Huntington's disease clinical trials?
Are there specific biomarkers associated with reliable oculomotor recordings in Huntington's disease patients?
What adverse events are commonly reported in Huntington's disease trials using eye-tracking devices?
What combination therapies or devices are being explored alongside video-oculography for Huntington's disease?
Trial Locations
- Locations (1)
Centre Hospitalier Universitaire
🇫🇷Angers, France
Centre Hospitalier Universitaire🇫🇷Angers, FranceD MileaContactdamilea@chu-angers.fr